Research & Publications
Clinical studies using mesenchymal stem cells on Covid-19.
Led by our stem cell experts, CryoCord group has been involved in many researches and publications over the years. Below are publications of researches conducted by our experts and their associates.
Ongoing Clinical Trials
Umbilical Cord derived Mesenchymal Stem Cell as Therapeutic Option for Refractory/ Complex Anal Fistula Associated with Crohn’s Disease
Purpose of study:
Exploring stem cells as a therapeutic option to treat perianal fistula in patients with Crohn’s disease.
Lead/ Principal Investigator:
Prof. Dr. April Camilla Roslani
University of Malaya Medical Centre
This study is approved by the Malaysia Ministry of Health and National Pharmaceutical Regulatory Agency.
NPRA’s Clinical Trial Exemption (CTX): CTX-220107
NMMR ID.: NMRR-21-1390-60766
Clinicaltrial.gov ID: NCT05039411
- Age 18 years & above
- Diagnosed with refractory/complex perianal fistula associated with Crohn’s disease
- Not pregnant or breastfeeding
- Do not have active cancer or on remission of less than 5 years
- Do not have HIV, HBV, HCV, or Treponema infection
*additional criteria apply*
For enrolment and more information, kindly contact:
Clinical site PIC:
Prof. Dr. April Camilla Roslani (Principal Investigator)
+603-7949 2070 / +603-7949 2441 (Surgery Department Office)
+603-7949 2886 / +603-7949 2351 (Clinical Investigation Centre)